文献速递主动脉外科

遗传性胸主动脉瘤及夹层患者的分子特征与临床研究

Molecular characterization and clinical investigation of patients with heritable thoracic aortic aneurysm and dissection.
PubMed 文献 · J Thorac Cardiovasc Surg · 2022-11-12

纳入2013至2022年本院1095例胸主动脉瘤及夹层患者,行二代测序及多重连接依赖探针扩增,并做嵌合体分析。83.5%综合征型与18.7%非综合征型患者检出致病性变异。致病性及意义未明变异组主动脉事件年龄更轻、再干预风险更高,FBN1单倍剂量不足变异者无再干预生存短于显性负效应变异者。

要点

  • 1095例胸主动脉瘤及夹层患者中检出376个致病性变异。
  • 致病性及意义未明变异组较基因阴性者主动脉事件年龄更轻、再干预风险更高。
  • FBN1单倍剂量不足变异者无再干预生存短于显性负效应变异者。

核心结论

  • 研究扩展了遗传性胸主动脉瘤及夹层的遗传谱,提示拷贝数变异和嵌合体变异占致病改变的小部分。
  • 阳性遗传结果可能对主动脉事件严重程度和术后风险分层有预测价值。

研究设计与样本

  • 研究纳入2013至2022年本院收治的1095例胸主动脉瘤及夹层患者,采用二代测序和多重连接依赖探针扩增检测,并额外进行嵌合体分析以明确遗传病因。

主要发现

  • 在83.5%的综合征型胸主动脉瘤及夹层患者和18.7%的非综合征型患者中检出376个致病性变异,包括8个拷贝数变异和2个嵌合体变异。
  • 致病性组和意义未明变异组患者较基因阴性者主动脉事件年龄更轻、主动脉再干预风险更高。
  • FBN1单倍剂量不足变异患者较FBN1显性负效应变异患者无再干预生存期更短。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Thoracic aortic aneurysm and dissection has a genetic predisposition and a variety of clinical manifestations. This study aimed to investigate the clinical and molecular characterizations of patients with thoracic aortic aneurysm and dissection and further explore the relationship between the genotype and phenotype, as well as their postoperative outcomes. METHODS: A total of 1095 individuals with thoracic aortic aneurysm and dissection admitted to our hospital between 2013 and 2022 were included. Next-generation sequencing and multiplex ligation-dependent probe amplification were performed, and mosaicism analysis was additionally implemented to identify the genetic causes. RESULTS: A total of 376 causative variants were identified in 83.5% of patients with syndromic thoracic aortic aneurysm and dissection and 18.7% of patients with nonsyndromic thoracic aortic aneurysm and dissection, including 8 copy number variations and 2 mosaic variants. Patients in the "pathogenic" and "variant of uncertain significance" groups had younger ages of aortic events and higher aortic reintervention risks compared with genetically negative cases. In addition, patients with FBN1 haploinsufficiency variants had shorter reintervention-free survival than those with FBN1 dominant negative variants. CONCLUSIONS: Our data expanded the genetic spectrum of heritable thoracic aortic aneurysm and dissection and indicated that copy number variations and mosaic variants contributed to a small proportion of the disease-causing alterations. Moreover, positive genetic results might have a possible predictive value for aortic event severity and postoperative risk stratification.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Yang H, Shen H, Zhu G, et al. Molecular characterization and clinical investigation of patients with heritable thoracic aortic aneurysm and dissection. J Thorac Cardiovasc Surg. 2022. PMID: 36517271. doi:10.1016/j.jtcvs.2022.11.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。